raloxifene hydrochloride has been researched along with Uterine Hemorrhage in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
Alam, J; Bhattoa, HP; Cox, DA; Dowsett, SA; Goldstein, SR; Muram, D; Neven, P; Sipos, A | 1 |
Benedetti-Panici, P; Cano, A; de Villiers, T; Hillard, T; Lunde, T; Marinescu, B; Neven, P; Nickelsen, T; Peer, E; Quail, D; Tiitinen, A | 1 |
Shintani, M | 1 |
Bontis, J; Dinas, K; Tsalikis, T; Zafrakas, M; Zepiridis, L | 1 |
Davies, GC; Huster, WJ; Lakshmanan, M; Lu, Y; Plouffe, L | 1 |
Body, JJ; Sternon, J | 1 |
Eriksen, EF | 1 |
Grow, DR; Reece, MT | 1 |
4 review(s) available for raloxifene hydrochloride and Uterine Hemorrhage
Article | Year |
---|---|
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
[Which is the better choice, estrogen or SERMs in postmenopausal women?].
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hip Fractures; Hot Flashes; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Uterine Hemorrhage | 2004 |
[Raloxifene].
Topics: Breast Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Menopause; Middle Aged; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2000 |
The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception.
Topics: Contraceptive Agents, Female; Estrogen Antagonists; Female; Humans; Neovascularization, Physiologic; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Hemorrhage | 2000 |
3 trial(s) available for raloxifene hydrochloride and Uterine Hemorrhage
Article | Year |
---|---|
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.
Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; Female; Genital Diseases, Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Uterine Hemorrhage; Vaginitis; Vulvitis | 2012 |
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
Topics: Aged; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Single-Blind Method; Time Factors; Treatment Outcome; Uterine Diseases; Uterine Hemorrhage | 2003 |
Adverse events reported by postmenopausal women in controlled trials with raloxifene.
Topics: Adult; Aged; Breast Diseases; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Middle Aged; Pain; Piperidines; Postmenopause; Raloxifene Hydrochloride; Uterine Hemorrhage | 1999 |
2 other study(ies) available for raloxifene hydrochloride and Uterine Hemorrhage
Article | Year |
---|---|
Endometrial lesions causing uterine bleeding in postmenopausal women receiving raloxifene.
Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrium; Female; Humans; Osteoporosis, Postmenopausal; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Diseases; Uterine Hemorrhage | 2005 |
[Raloxifene (Celvista, Evista)].
Topics: Arteriosclerosis; Bone and Bones; Breast Neoplasms; Controlled Clinical Trials as Topic; Endometrium; Female; Fractures, Bone; Heart Diseases; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thromboembolism; Uterine Hemorrhage | 2000 |